Designer cannabinoids could be the key to pain relief without adverse effects
Iain R. Greig () and
Ruth A. Ross
Nature, 2025, vol. 640, issue 8057, 45-46
Abstract:
Current approaches to pain relief are falling short. Chemically modifying a synthetic cannabinoid could enable scientists to capitalize on the body’s natural pain-killing pathway without evoking drug tolerance or psychoactivity.
Keywords: Drug discovery; Brain; Biochemistry; Structural biology (search for similar items in EconPapers)
Date: 2025
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.nature.com/articles/d41586-025-00546-w Abstract (text/html)
Access to the full text of the articles in this series is restricted.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:640:y:2025:i:8057:d:10.1038_d41586-025-00546-w
Ordering information: This journal article can be ordered from
https://www.nature.com/
DOI: 10.1038/d41586-025-00546-w
Access Statistics for this article
Nature is currently edited by Magdalena Skipper
More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().